Search
for
Did you mean Angiotensin-Converting Enzyme?
Sort by
Research 30 of 1000+
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Culprits of Medication-Induced Telogen Effluvium, Part 2
- Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Association of ACE2, Insulin Resistance, and Other Parameters in Obese Polycystic Ovary Syndrome Patients Infected with COVID-19
- ACE2 Inhibits Dermal Regeneration Through Ang II in Tissue Expansion
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- An Unusual Cause of Hair Loss
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Lisinopril-Induced Alopecia: A Case Report
- Comparison of the pharmacoeconomic profiles of treatment regimens for field pattern actinic keratoses
- QUINAPRIL
- Association of common medication with prostate-specific antigen level in 45-year-old German men: Results of the PROBASE trial
- Bioactive peptides derived from food proteins preventing lifestyle‐related diseases
- Sarcoidosis Presenting as Frontal Fibrosing Alopecia: A Master Mimicker or a Coincidental Finding?
- Evaluation of risk of SSRI-associated impotence and low libido in men exposed to finasteride
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- Association between angiotensin‐converting enzyme gene insertion deletion polymorphism and androgenetic alopecia susceptibility among Egyptian patients: A preliminary case‐controlled study
- [Drug induced alopecia].
- Role of ACE2 polymorphism in COVID-19: impact of age
- Congenital adrenal hyperplasia
- Nanocarriers for Improved Delivery of Angiotensin-(1-7)
- Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
- A computationally inferred regulatory heart aging model including post-transcriptional regulations
- Conference 2022, The Sequel
- Vitamin D, Lipid Metabolism and Prostate Cancer
- An Update of Congenital Adrenal Hyperplasia
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?